ENANTA PHARMACEUTICALS, INC Other Comprehensive Income (Loss), Net of Tax
ENANTA PHARMACEUTICALS, INC (ENTA) reported Other Comprehensive Income (Loss), Net of Tax of -$286.00 thousand for the 12-month period ending 2018-09-30, per its 10-K filed 2018-11-29.
Discontinued › Income Statement
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2018-11-29
- ENANTA PHARMACEUTICALS, INC other comprehensive income (loss), net of tax for the quarter ending 2018-09-30 was $197.00K, a 688.00% increase year-over-year.
- ENANTA PHARMACEUTICALS, INC other comprehensive income (loss), net of tax for the quarter ending 2018-06-30 was $199.00K.
- ENANTA PHARMACEUTICALS, INC other comprehensive income (loss), net of tax for the quarter ending 2018-03-31 was -$336.00K.
- ENANTA PHARMACEUTICALS, INC other comprehensive income (loss), net of tax for the quarter ending 2017-12-31 was -$346.00K.
- ENANTA PHARMACEUTICALS, INC other comprehensive income (loss), net of tax for fiscal 2018 was -$286.00K.
- ENANTA PHARMACEUTICALS, INC other comprehensive income (loss), net of tax for fiscal 2017 was -$131.00K.
- ENANTA PHARMACEUTICALS, INC other comprehensive income (loss), net of tax for fiscal 2016 was -$14.00K, a 110.53% decline from fiscal 2015.
- ENANTA PHARMACEUTICALS, INC other comprehensive income (loss), net of tax for fiscal 2015 was $133.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2018-09-30 | $197.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-29 | $396.00K derived: sum of 2 quarters · filed 2018-11-29 | $60.00K derived: sum of 3 quarters · filed 2018-11-29 | -$286.00K 10-K · filed 2018-11-29 |
| 2018-06-30 | $199.00K 10-Q · filed 2018-08-09 | -$137.00K derived: sum of 2 quarters · filed 2018-08-09 | -$483.00K 10-Q · filed 2018-08-09 | -$458.00K derived: sum of 4 quarters · filed 2018-11-29 |
| 2018-03-31 | -$336.00K 10-Q · filed 2018-05-10 | -$682.00K 10-Q · filed 2018-05-10 | -$657.00K derived: sum of 3 quarters · filed 2018-11-29 | -$686.00K derived: sum of 4 quarters · filed 2018-11-29 |
| 2017-12-31 | -$346.00K 10-Q · filed 2018-02-09 | -$321.00K derived: sum of 2 quarters · filed 2018-11-29 | -$350.00K derived: sum of 3 quarters · filed 2018-11-29 | -$373.00K derived: sum of 4 quarters · filed 2018-11-29 |
| 2017-09-30 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-29 | -$4.00K derived: sum of 2 quarters · filed 2018-11-29 | -$27.00K derived: sum of 3 quarters · filed 2018-11-29 | -$131.00K 10-K · filed 2018-11-29 |
| 2017-06-30 | -$29.00K 10-Q · filed 2018-08-09 | -$52.00K derived: sum of 2 quarters · filed 2018-08-09 | -$156.00K 10-Q · filed 2018-08-09 | -$254.00K derived: sum of 4 quarters · filed 2018-11-29 |
| 2017-03-31 | -$23.00K 10-Q · filed 2018-05-10 | -$127.00K 10-Q · filed 2018-05-10 | -$225.00K derived: sum of 3 quarters · filed 2018-11-29 | -$309.00K derived: sum of 4 quarters · filed 2018-11-29 |
| 2016-12-31 | -$104.00K 10-Q · filed 2018-02-09 | -$202.00K derived: sum of 2 quarters · filed 2018-11-29 | -$286.00K derived: sum of 3 quarters · filed 2018-11-29 | $104.00K derived: sum of 4 quarters · filed 2018-11-29 |
| 2016-09-30 | -$98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-29 | -$182.00K derived: sum of 2 quarters · filed 2018-11-29 | $208.00K derived: sum of 3 quarters · filed 2018-11-29 | -$14.00K 10-K · filed 2018-11-29 |
| 2016-06-30 | -$84.00K 10-Q · filed 2017-08-09 | $306.00K derived: sum of 2 quarters · filed 2017-08-09 | $84.00K 10-Q · filed 2017-08-09 | $191.00K derived: sum of 4 quarters · filed 2017-12-11 |
| 2016-03-31 | $390.00K 10-Q · filed 2017-05-10 | $168.00K 10-Q · filed 2017-05-10 | $275.00K derived: sum of 3 quarters · filed 2017-12-11 | $218.00K derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-12-31 | -$222.00K 10-Q · filed 2017-02-09 | -$115.00K derived: sum of 2 quarters · filed 2017-12-11 | -$172.00K derived: sum of 3 quarters · filed 2017-12-11 | -$94.00K derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-09-30 | $107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | $50.00K derived: sum of 2 quarters · filed 2017-12-11 | $128.00K derived: sum of 3 quarters · filed 2017-12-11 | $133.00K 10-K · filed 2017-12-11 |
| 2015-06-30 | -$57.00K 10-Q · filed 2016-08-09 | $21.00K derived: sum of 2 quarters · filed 2016-08-09 | $26.00K 10-Q · filed 2016-08-09 | -$70.00K derived: sum of 4 quarters · filed 2016-12-09 |
| 2015-03-31 | $78.00K 10-Q · filed 2016-05-10 | $83.00K 10-Q · filed 2016-05-10 | -$13.00K derived: sum of 3 quarters · filed 2016-12-09 | -$78.00K derived: sum of 4 quarters · filed 2016-12-09 |
| 2014-12-31 | $5.00K 10-Q · filed 2016-02-09 | -$91.00K derived: sum of 2 quarters · filed 2016-12-09 | -$156.00K derived: sum of 3 quarters · filed 2016-12-09 | -$127.00K derived: sum of 4 quarters · filed 2016-12-09 |
| 2014-09-30 | -$96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-09 | -$161.00K derived: sum of 2 quarters · filed 2016-12-09 | -$132.00K derived: sum of 3 quarters · filed 2016-12-09 | -$98.00K 10-K · filed 2016-12-09 |
| 2014-06-30 | -$65.00K 10-Q · filed 2015-08-10 | -$36.00K derived: sum of 2 quarters · filed 2015-08-10 | -$2.00K 10-Q · filed 2015-08-10 | $90.00K derived: sum of 4 quarters · filed 2015-12-11 |
| 2014-03-31 | $29.00K 10-Q · filed 2015-05-08 | $63.00K 10-Q · filed 2015-05-08 | $155.00K derived: sum of 3 quarters · filed 2015-12-11 | $68.00K derived: sum of 4 quarters · filed 2015-12-11 |
| 2013-12-31 | $34.00K 10-Q · filed 2015-02-06 | $126.00K derived: sum of 2 quarters · filed 2015-12-11 | $39.00K derived: sum of 3 quarters · filed 2015-12-11 | $36.00K derived: sum of 4 quarters · filed 2015-12-11 |
| 2013-09-30 | $92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | $5.00K derived: sum of 2 quarters · filed 2015-12-11 | $2.00K derived: sum of 3 quarters · filed 2015-12-11 | -$12.00K 10-K · filed 2015-12-11 |
| 2013-06-30 | -$87.00K 10-Q · filed 2014-08-12 | -$90.00K derived: sum of 2 quarters · filed 2014-08-12 | -$104.00K 10-Q · filed 2014-08-12 | -$79.00K derived: sum of 4 quarters · filed 2014-12-11 |
| 2013-03-31 | -$3.00K 10-Q · filed 2014-05-12 | -$17.00K 10-Q · filed 2014-05-12 | $8.00K derived: sum of 3 quarters · filed 2014-12-11 | $8.00K derived: sum of 4 quarters · filed 2014-12-11 |
| 2012-12-31 | -$14.00K 10-Q · filed 2014-02-13 | $11.00K derived: sum of 2 quarters · filed 2014-12-11 | $11.00K derived: sum of 3 quarters · filed 2014-12-11 | -$6.00K derived: sum of 4 quarters · filed 2014-12-11 |
| 2012-09-30 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-11 | $25.00K derived: sum of 2 quarters · filed 2014-12-11 | $8.00K derived: sum of 3 quarters · filed 2014-12-11 | $11.00K 10-K · filed 2014-12-11 |
| 2012-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-12 | -$17.00K derived: sum of 2 quarters · filed 2013-08-12 | -$14.00K 10-Q · filed 2013-08-12 | |
| 2012-03-31 | -$17.00K 10-Q · filed 2013-05-15 | -$14.00K 10-Q · filed 2013-05-15 | ||
| 2011-09-30 | -$1.00K 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |